Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	20.6	30.15	46.33	69.55	34.27	15.75
Short-Term Investments	-	-	-	-	-	54.6
Cash & Short-Term Investments	20.6	30.15	46.33	69.55	34.27	70.35
Cash Growth	-30.39%	-34.93%	-33.38%	102.92%	-51.29%	7.46%
Accounts Receivable	7.81	5.4	0.08	4.42	0.49	-
Inventory	1.97	2.24	2.46	1.02	-	-
Other Current Assets	3.74	4.76	2.31	2.55	4.36	3.97
Total Current Assets	34.13	42.54	51.18	77.53	39.12	74.33
Net Property, Plant & Equipment	1.66	1.86	2.58	3.62	5.33	5.5
Other Long-Term Assets	2.99	2.73	0.38	0.45	0.28	0.3
Total Assets	38.79	47.13	54.13	81.6	44.72	80.13
Accounts Payable	2.19	2.07	1.9	2.46	0.51	0.85
Accrued Expenses	12.25	12.84	13.51	13.86	2.66	3.27
Current Portion of Long-Term Debt	-	-	12.94	-	-	41.69
Current Portion of Leases	0.74	0.75	0.67	0.7	0.3	0.25
Unearned Revenue	1.03	0.78	-	-	-	-
Total Current Liabilities	16.22	16.44	29.01	17.02	3.46	46.06
Long-Term Debt	-	-	30.98	42.87	-	-
Long-Term Leases	0.7	0.89	1.35	1.94	1.23	1.47
Other Long-Term Liabilities	5.81	5.07	2.65	-	-	-
Total Long-Term Liabilities	6.51	5.95	34.98	44.81	1.23	1.47
Total Liabilities	22.73	22.39	63.99	61.83	4.69	47.52
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	350.65	349.65	297.17	250.21	203.48	171.6
Accumulated Other Comprehensive Income	-	-	-	-	-	-0.03
Retained Earnings	-334.6	-324.91	-307.03	-230.45	-163.45	-138.97
Shareholders' Equity	16.06	24.74	-9.86	19.76	40.03	32.61
Total Liabilities & Equity	38.79	47.13	54.13	81.6	44.72	80.13
Total Debt	1.44	1.63	45.94	45.51	1.53	43.41
Net Cash (Debt)	19.16	28.52	0.39	24.04	32.75	26.95
Net Cash Growth	-32.82%	7211.79%	-98.38%	-26.60%	21.53%	-4.67%
Net Cash Per Share	1.41	2.68	0.07	5.30	9.59	9.96
Book Value	16.06	24.74	-9.86	19.76	40.03	32.61
Book Value Per Share	1.18	2.32	-1.90	4.36	11.72	12.06
Tangible Book Value	16.06	24.74	-9.86	19.76	40.03	32.61
Tangible Book Value Per Share	1.18	2.32	-1.90	4.36	11.72	12.06

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q